Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CXCR5 Stable Cell Line

    [CAT#: S01YF-0923-PY48]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    CXCR5
    Target Family
    Chemokine Family
    Target Protein Species
    Human
    Host Cell Type
    ACHN;Caki-2;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Immunology Research
    Related Diseases
    Intraocular Lymphoma;Lymphoma
    Gene ID
    Human: 643
    UniProt ID
    Human: P32302

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    CXCR5, another chemokine receptor, has been identified as a significant factor in various autoimmune diseases. The CXCL13/CXCR5 axis, in particular, has been discussed for its pathogenic roles in these diseases, suggesting CXCL13 as a potential biomarker and therapeutic target. In cancer research, the CXCL13/CXCR5 signaling has been found to modulate cancer and immune cells, promoting lymphocyte infiltration and increasing the antitumor immune response. Moreover, in rheumatoid arthritis progression, the CXCL13/CXCR5 axis has been shown to facilitate endothelial progenitor cell homing and angiogenesis. In the context of nasopharyngeal carcinoma, the induction of specific T cells links innate inflammation to immune privilege in tumor-associated tertiary lymphoid structures, indicating a potential therapeutic avenue.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CXCR5 Stable Cell Line (S01YF-0923-PY48). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Charles (Verified Customer)

    What is the significance of the CXCL13/CXCR5 axis in autoimmune diseases? Jun 18 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The CXCL13/CXCR5 axis plays a pathogenic role in autoimmune diseases, and CXCL13 has potential as a disease biomarker and therapeutic target in these conditions. Jun 18 2021

    chat Elizabeth (Verified Customer)

    How does the CXCL13/CXCR5 signaling influence cancer treatments, especially with immune checkpoint inhibitors? Jun 23 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The CXCL13/CXCR5 signaling modulates cancer and immune cells to promote lymphocyte infiltration, activation by tumor antigens, and differentiation, thereby enhancing the antitumor immune response. Jun 23 2020

    Published Data

    Fig.1 CXCL13/CXCR5 axis promoted ccRCC cells proliferation.

    Suppression of CXCR5 gene expression hampered CXCL13-induced cell growth in ccRCC cells, as confirmed through the cell proliferation assay (evaluated using Student's t-test, *P < 0.05).

    Ref: Zheng, Zaosong, et al. "CXCL13/CXCR5 axis predicts poor prognosis and promotes progression through PI3K/AKT/mTOR pathway in clear cell renal cell carcinoma." Frontiers in oncology 8 (2019): 682.

    Pubmed: 30723697

    DOI: 10.3389/fonc.2018.00682

    Research Highlights

    Zacharias ZR, Houtman JCD. "OMIP-099: 31-color spectral flow cytometry panel to investigate the steady-state ." Cytometry. Part A : the journal of the International Society for Analytical , 2023.
    The authors have developed a novel 31-color panel to define the steady-state phenotype of T cells in human peripheral blood (Table 1). The panel was optimized using cryopreserved peripheral blood mononuclear cells (PBMC) and includes markers such as CD45RA, CD45RO, CCR7, and CD95, which were carefully selected to characterize the main subsets (e.g., naive, T(EM), T(CM), T(EMRA), T(SCM), etc.) of CD4, CD8, and gammadelta T cells. Additionally, the panel includes markers to identify differentiation status (CD27, CD28), activation/antigen experience status (CD11a, CD49d, CD38, HLA-DR, CD56, CD39), co-inhibitory marker expression (PD-1, TIM-3), and CD4 T helper subsets (CXCR3, CXCR5, CCR4, CCR6, Foxp3, CD25, CD127). This optimized panel offers a comprehensive evaluation of the steady-state phenotype of human T cells.
    Pubmed: 37814476   DOI: 10.1002/cyto.a.24799

    Tang HY, et al. "[Identification and preliminary validation of potential biomarkers in the ." Zhonghua yi xue za zhi, 2023.
    The study aimed to compare the peripheral blood mononuclear cell (PBMC) transcripts of patients with atopic dermatitis (AD) and healthy individuals, and to identify and validate potential biomarkers of AD. Samples were collected from 9 AD patients and 10 healthy controls between January 2021 and May 2022 at the Dermatology and Cosmetic Center of the Third Affiliated Hospital of Chongqing Medical University. RNA-sequencing (RNA-seq) was used to analyze PBMC transcriptome and differential gene expression. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein-protein interaction (PPI) network analysis were conducted to identify differentially expressed genes (DEGs). Quantitative real-time PCR (qRT-PCR) was used to validate potential biomarkers. Results showed that the AD group had 1,044 DEGs, including 668 up-regulated and 376 down-regulated genes, compared to healthy controls. Additionally, differential variable splicing (AS) analysis revealed a high proportion of mutually exclusive exons (46.74%) and skipped exons (31.01%) in AD patients. GO and KEGG enrichment analysis suggested that AD is associated with DEGs involved in the inflammatory response, cytokine interaction, and signaling pathways. PPI analysis and comprehensive enrichment analysis identified 8 candidate genes (CCL4, CCR3, CXCR5, NFKBIA, CXCL1, IL-1B, CCL20, LY96), which were verified by qRT-PCR and consistent with RNA-seq results. In conclusion, potential biomarkers for AD (CCL4, CCR3, CXCR5, NFKBIA, CXCL1, IL-1B, CCL20, LY96) were identified, suggesting their involvement in the pathogenesis of AD.
    Pubmed: 37813654   DOI: 10.3760/cma.j.cn112137-20230128-00128

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare